Ovarian Progression-Free Survival Acceptable If Trial Is Powered For Survival

Progression-free survival is an acceptable basis for accelerated approval of ovarian cancer agents, so long as trials are powered for survival, panelists at FDA's April 26 Ovarian Cancer Endpoint Workshop in Bethesda, Md. said